Seeking Alpha EN

ADMA Biologics drops amid short report from Culper Research

Mar 24, 2026 &03442424202631; 18:44 UTC seekingalpha.com Trending 2/5

Read original on seekingalpha.com ↗

↘

Negative for markets

Sentiment score: -72/100

High impact Immediate effect (hours)

WHAT THIS MEANS

ADMA Biologics faces a fresh short report from Culper Research, triggering immediate selling pressure. The stock is likely experiencing a sharp intraday decline as the market processes the negative catalyst.

AI CONFIDENCE

68% High

SENTIMENT GAUGE

NEWS POWER SCORE

AFFECTED ASSETS

↓

ADMA

ADMAStock

Expected to decline

Fresh short report from Culper Research published 6 minutes ago; market has not fully absorbed the negative catalyst; VIX elevated at 26.65 suggesting broader risk-off sentiment supporting downside momentum

PRICE HISTORY

Loading chart...

⚡ SUGGESTED ACTION

Short report is fresh and unpriced; expect continued downside into market close. Avoid long entries; consider short positions only if stock stabilizes above key support. Monitor for any company response or short-squeeze reversal. [MOVE:-4.5%]

KEY SIGNALS

Fresh short report (6 min old) — real-time catalystVIX +1.91% — risk-off environment favors shortsBiotech sector vulnerability to negative researchLikely gap-down or continued selling into close

SECTORS INVOLVED

HealthcareBiotechnology

Analysis generated on Mar 24, 2026 at 18:50 UTC

Disclaimer: This analysis is generated by artificial intelligence for informational purposes only and does not constitute financial advice, investment recommendation, or solicitation. Original reporting by Seeking Alpha. Always conduct your own research and consult a qualified financial advisor before making investment decisions.

ADMA Biologics drops amid short report from Culper Research

RELATED INTELLIGENCE